Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human Endothelial Membrane as a Structural Prototype: A Comparative Analysis with <i>Artemia salina</i> Endothelial-like Cell.

International journal of molecular sciences·2026
Same author

Molecular Mediated Angiogenesis and Vasculogenesis Networks.

International journal of molecular sciences·2025
Same author

SARS-CoV-2 Spike Protein Interaction Space.

International journal of molecular sciences·2023
Same author

Atoms-In-Molecules' Faces of Chemical Hardness by Conceptual Density Functional Theory.

Molecules (Basel, Switzerland)·2022
Same author

The Density Functional Theory Account of Interplaying Long-Range Exchange and Dispersion Effects in Supramolecular Assemblies of Aromatic Hydrocarbons with Spin.

Molecules (Basel, Switzerland)·2022
Same author

Three-Body Excitations in Fock-Space Coupled-Cluster: Fourth Order Perturbation Correction to Electron Affinity and Its Relation to Bondonic Formalism.

International journal of molecular sciences·2021

Related Experiment Video

Updated: Jun 1, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Residual-QSAR. Implications for genotoxic carcinogenesis.

Mihai V Putz1

  • 1Laboratory of Computational and Structural Physical Chemistry, Chemistry Department, West University of Timişoara, Pestalozzi Street No,16, Timişoara, RO-300115, Romania. mv_putz@yahoo.com.

Chemistry Central Journal
|June 15, 2011
PubMed
Summary

This study applies quantitative structure-activity relationship ((Q)SAR) methods to understand genotoxic carcinogenesis in non-congeneric molecules. The residual-QSAR approach reveals mechanistic pathways of ligand-DNA interactions for improved chemical safety assessments.

More Related Videos

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

Quantification of three DNA Lesions by Mass Spectrometry and Assessment of Their Levels in Tissues of Mice Exposed to Ambient Fine Particulate Matter
12:15

Quantification of three DNA Lesions by Mass Spectrometry and Assessment of Their Levels in Tissues of Mice Exposed to Ambient Fine Particulate Matter

Published on: May 29, 2019

Related Experiment Videos

Last Updated: Jun 1, 2026

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

Quantification of three DNA Lesions by Mass Spectrometry and Assessment of Their Levels in Tissues of Mice Exposed to Ambient Fine Particulate Matter
12:15

Quantification of three DNA Lesions by Mass Spectrometry and Assessment of Their Levels in Tissues of Mice Exposed to Ambient Fine Particulate Matter

Published on: May 29, 2019

Area of Science:

  • Computational toxicology
  • Medicinal chemistry
  • Carcinogenesis research

Background:

  • Distinguishes between genotoxic and epigenetic carcinogenesis, focusing on non-congeneric molecules.
  • Highlights the importance of quantitative structure-activity relationship ((Q)SAR) studies under OECD regulations.
  • Emphasizes the need for physicochemical parameters to describe genotoxicity via a general mechanism.

Purpose of the Study:

  • To systematically apply (Q)SAR principles to elucidate carcinogenic mechanisms of genotoxic molecules in rats.
  • To utilize ligand-DNA interaction endpoints for selecting relevant Hansch physicochemical parameters.
  • To apply the residual, self-consistent (Q)SAR method for mechanistic insights into genotoxic carcinogenesis.

Main Methods:

  • Employed the residual-QSAR method, comparing direct and residual structural information against observed activity.
  • Used PM3 semiempirical quantum methods to compute hydrophobicity, polarizability, and stericity parameters.
  • Applied the minimum paths principle to integrate various (Q)SAR models and identify mechanistic pathways.

Main Results:

  • The residual-QSAR method yielded high correlations, suitable for describing slow carcinogenesis in non-congeneric molecules.
  • Identified alpha, beta, and gamma paths connecting structural indicators to the genotoxic endpoint.
  • The molecular mechanism preserved self-consistency, detailing ligand-DNA interactions across cellular stages.

Conclusions:

  • The residual-QSAR principle is suitable for mechanistic assessment of genotoxic carcinogenesis, especially for non-congeneric compounds.
  • The method's self-consistency and applicability to diverse molecules support its use in conceptual mechanistic evaluation.
  • Potential extension to include molecular fragments and structural alerts for more detailed chemical-biological interaction mapping.